MARC 닫기

• LDR

  00000cam u2200205 i 4500

• 001

  000000537330

• 005

  20220128153523

• 006

  m d

• 007

  cr cn|||||||||

• 008

  210102s2020 dcua ob 000 0 eng

• 010

  ▼a  2020949045

• 016

  ▼a  101774876
  ▼2  DNLM

• 019

  ▼a  1227692209

• 020

  ▼a  9780309671163
  ▼q  (electronic bk.)

• 020

  ▼a  0309671167
  ▼q  (electronic bk.)

• 020

  ▼z  9780309671149

• 020

  ▼z  0309671140

• 020

  ▼z  9780309671132

• 020

  ▼z  0309671132

• 035

  ▼a  2742053
  ▼b  (N$T)

• 035

  ▼a  (OCoLC)1227386525
  ▼z  (OCoLC)1227692209

• 040

  ▼a  NLM
  ▼b  eng
  ▼c  NLM
  ▼d  OCLCF
  ▼d  YDX
  ▼d  N$T
  ▼d  TXM
  ▼d  UKAHL
  ▼d  EBLCP
  ▼d  OCLCO
  ▼d  248023
  ▼d  YDX
  ▼e  rda

• 042

  ▼a  pcc

• 049

  ▼a  MAIN

• 050

  ▼a  QH447
  ▼b  .H4758 2020

• 060

  ▼a  QU 470

• 082

  ▼a  572.86
  ▼2  23

• 245

  ▼a  Heritable human genome editing /
  ▼c  International Commission on the Clinical Use of Human Germline Genome Editing ; National Academy of Medicine ; National Academy of Sciences ; and the Royal Society.

• 246

  ▼a  Human genome

• 260

  ▼a  Washington, DC:
  ▼b  The National Academies Press,
  ▼c  [2020].

• 300

  ▼a  1 online resource (1 PDF file (xviii, 219 pages)):
  ▼b  color illustrations.

• 336

  ▼a  text
  ▼b  txt
  ▼2  rdacontent

• 337

  ▼a  computer
  ▼b  c
  ▼2  rdamedia

• 338

  ▼a  online resource
  ▼b  cr
  ▼2  rdacarrier

• 490

  ▼a  Consensus study report

• 504

  ▼a  Includes bibliographical references.

• 505

  ▼a  Intro -- FrontMatter -- Special Acknowledgments -- Foreword -- Contents -- Boxes and Figures -- Summary -- 1 Introduction -- 2 The State of the Science -- 3 Potential Applications of Heritable Human Genome Editing -- 4 A Translational Pathway to Limited and Controlled Clinical Applications of Heritable Human Genome Editing -- 5 National and International Governance of Heritable Human Genome Editing -- References -- Appendix A: Information Sources and Methods -- Appendix B: Commissioner Biographies -- Appendix C: Glossary -- Appendix D: Acronyms and Abbreviations -- Acknowledgment of Reviewers

• 520

  ▼a  "Heritable human genome editing - making changes to the genetic material of eggs, sperm, or any cells that lead to their development, including the cells of early embryos, and establishing a pregnancy - raises not only scientific and medical considerations but also a host of ethical, moral, and societal issues. Human embryos whose genomes have been edited should not be used to create a pregnancy until it is established that precise genomic changes can be made reliably and without introducing undesired changes - criteria that have not yet been met, says Heritable Human Genome Editing. From an international commission of the U.S. National Academy of Medicine, U.S. National Academy of Sciences, and the U.K.'s Royal Society, the report considers potential benefits, harms, and uncertainties associated with genome editing technologies and defines a translational pathway from rigorous preclinical research to initial clinical uses, should a country decide to permit such uses. The report specifies stringent preclinical and clinical requirements for establishing safety and efficacy, and for undertaking long-term monitoring of outcomes. Extensive national and international dialogue is needed before any country decides whether to permit clinical use of this technology, according to the report, which identifies essential elements of national and international scientific governance and oversight."--
  ▼c  Publisher's website.

• 536

  ▼a  This activity was supported by Contract No. HHSN263201800029I / Order No. 75N98019F00852 from the U.S. National Institutes of Health, Grant No. 2019 HTH 009 from the Rockefeller Foundation, and Grant 218375/Z/19/Z from the Wellcome Trust, with additional support from the Royal Society of the United Kingdom, the Cicerone Endowment Fund of the U.S. National Academy of Sciences, and the NAM Initiatives Fund of the U.S. National Academy of Medicine. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.

• 588

  ▼a  Description based on online resource; title from digital title page (viewed on May 03, 2021).

• 590

  ▼a  Master record variable field(s) change: 050, 082

• 650

  ▼a  Human genome.

• 650

  ▼a  Gene editing.

• 650

  ▼a  Ethics.

• 650

  ▼a  Gene Editing.

• 650

  ▼a  Genome.

• 650

  ▼a  Quantitative Trait, Heritable.

• 650

  ▼a  Genomics
  ▼x  methods.

• 650

  ▼a  Ethics.
  ▼2  fast
  ▼0  (OCoLC)fst00915833

• 650

  ▼a  Gene editing.
  ▼2  fast
  ▼0  (OCoLC)fst02000662

• 650

  ▼a  Human genome.
  ▼2  fast
  ▼0  (OCoLC)fst00963101

• 655

  ▼a  Electronic books.

• 710

  ▼a  International Commission on the Clinical Use of Human Germline Genome Editing,
  ▼e  issuing body.

• 776

  ▼i  Print version:
  ▼a  Society, The Royal
  ▼t  Heritable Human Genome Editing.
  ▼d  Washington, D.C. : National Academies Press,c2021,
  ▼z  9780309671132

• 830

  ▼a  Consensus study report.

• 856

  ▼3  EBSCOhost
  ▼u  https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2742053

• 938

  ▼a  EBSCOhost
  ▼b  EBSC
  ▼n  2742053

• 938

  ▼a  YBP Library Services
  ▼b  YANK
  ▼n  17163959

• 938

  ▼a  ProQuest Ebook Central
  ▼b  EBLB
  ▼n  EBL6426686

• 938

  ▼a  YBP Library Services
  ▼b  YANK
  ▼n  301915094

• 938

  ▼a  Askews and Holts Library Services
  ▼b  ASKH
  ▼n  AH38277896

• 990

  ▼a  최영란

• 991

  ▼a  eBook

• 994

  ▼a  92
  ▼b  N$T